Evaluation of a fluorescent method (fluorescein diacetate and ethidium bromide solution) in the study of the viability Cryptococcus neoformans strains.
The effectiveness of the fluorescent viability test (fluorescein diacetate-FDA and ethidium bromide-EB-solution) compared to the plaque counting test (Miles & Misra M & M) was performed on 10 samples of Cryptococcus neoformans cultivated in Sabouraud dextrose agar at 25 degrees C. The optimum incubation period of 50 minutes was determined. Growth curves of the fungal strains studied based on the mean cell number were drawn for both the FDA & EB and M & M methods. The statistical evaluation (Student's T test) of the average sum of the viable cell counts showed that the FDA-EB method is more sensitive than the M & M test for the studied species. The growth curves of the samples usually followed a homogeneous pattern comparable to other non-dimorphic fungi.
D000818:Animals; D003454:Cryptococcus / Q000254:growth & development*; D003455:Cryptococcus neoformans / Q000166:cytology / Q000254:growth & development* / Q000472:pathogenicity; D004996:Ethidium; D005452:Fluoresceins; D008297:Male; D051379:Mice; D008828:Microbiological Techniques; D014774:Virulence
D005452:Fluoresceins; D004996:Ethidium; C018506:diacetylfluorescein